Immunologists at UNIGE have revealed a previously unknown anti-tumor role of CD4 T lymphocytes, marking a breakthrough that ...

Breast cancer often relapses in distant organs even when complete regression of primary tumors is achieved after initial ...

Cancer-fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal ...

A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) ...

Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to have improved survival following immunotherapy compared to patients without ...

Management of Patients With Upper Urinary Tract Transitional Cell Carcinoma Jay D Raman; Douglas S Scherr* Disclosures Nat Clin Pract Urol. 2007;4 (8):432-443. 0 ...

Management of Patients With Upper Urinary Tract Transitional Cell Carcinoma Jay D Raman; Douglas S Scherr* Disclosures Nat Clin Pract Urol. 2007;4 (8):432-443. 0 Diagnosis and Staging ...

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI ...

(HealthDay News) — Cancer treatments and genetic predisposition contribute to the risk of subsequent neoplasms (SNs) among long-term childhood cancer survivors, according to a study published ...